Shu‐Huei Tsai

2.0k total citations
28 papers, 1.7k citations indexed

About

Shu‐Huei Tsai is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Shu‐Huei Tsai has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pharmacology. Recurrent topics in Shu‐Huei Tsai's work include Inflammatory mediators and NSAID effects (6 papers), NF-κB Signaling Pathways (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Shu‐Huei Tsai is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), NF-κB Signaling Pathways (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Shu‐Huei Tsai collaborates with scholars based in Taiwan, Canada and United States. Shu‐Huei Tsai's co-authors include Shoei‐Yn Lin‐Shiau, Jen‐Kun Lin, Yu‐Chih Liang, Ming‐Shium Hsieh, Jen‐Kun Lin, Linda Chen, Yen‐Chou Chen, Shing‐Chuan Shen, Chih‐Peng Chang and Linda Chen and has published in prestigious journals such as PLoS ONE, Hepatology and FEBS Letters.

In The Last Decade

Shu‐Huei Tsai

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Huei Tsai Taiwan 19 822 252 220 202 192 28 1.7k
Hui Chang China 24 979 1.2× 155 0.6× 256 1.2× 464 2.3× 255 1.3× 57 2.1k
Jun Hee Lim South Korea 22 1.1k 1.3× 200 0.8× 129 0.6× 199 1.0× 202 1.1× 38 1.7k
Jean‐François Savouret France 27 779 0.9× 131 0.5× 435 2.0× 106 0.5× 208 1.1× 41 2.1k
Nica M. Borradaile Canada 22 916 1.1× 138 0.5× 161 0.7× 504 2.5× 187 1.0× 38 2.4k
Yoo‐Hyun Lee South Korea 21 909 1.1× 174 0.7× 72 0.3× 172 0.9× 139 0.7× 72 1.7k
Keon Wook Kang South Korea 30 1.7k 2.1× 178 0.7× 97 0.4× 292 1.4× 295 1.5× 87 2.7k
Marthandam Asokan Shibu Taiwan 24 957 1.2× 167 0.7× 75 0.3× 231 1.1× 246 1.3× 98 1.9k
Pedro Michaluart Brazil 16 708 0.9× 218 0.9× 359 1.6× 74 0.4× 148 0.8× 19 1.7k
Zhou‐Yan Bian China 31 1.1k 1.4× 163 0.6× 56 0.3× 189 0.9× 258 1.3× 63 2.2k
Roberta Giordo Italy 25 697 0.8× 84 0.3× 124 0.6× 88 0.4× 130 0.7× 56 1.8k

Countries citing papers authored by Shu‐Huei Tsai

Since Specialization
Citations

This map shows the geographic impact of Shu‐Huei Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Huei Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Huei Tsai more than expected).

Fields of papers citing papers by Shu‐Huei Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Huei Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Huei Tsai. The network helps show where Shu‐Huei Tsai may publish in the future.

Co-authorship network of co-authors of Shu‐Huei Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Huei Tsai. A scholar is included among the top collaborators of Shu‐Huei Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Huei Tsai. Shu‐Huei Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yiren, et al.. (2024). Patient Cranial Angle and Intrafractional Stability in CyberKnife Robotic Radiosurgery: A Retrospective Analysis. Technology in Cancer Research & Treatment. 23. 2233976946–2233976946. 1 indexed citations
2.
Thakur, Avinash, Jasper Wong, Evan Y. Wang, et al.. (2019). Hepatocyte Nuclear Factor 4‐Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse Liver. Hepatology. 70(4). 1360–1376. 51 indexed citations
3.
Cheng, Jung‐Chien, Evan Y. Wang, Yuyin Yi, et al.. (2018). S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation. Molecular Cancer Research. 16(10). 1543–1555. 58 indexed citations
4.
Wang, Evan Y., Jung‐Chien Cheng, Avinash Thakur, et al.. (2018). YAP transcriptionally regulates ErbB2 to promote liver cell proliferation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(9). 854–863. 18 indexed citations
5.
Yi, Yuyin, Shu‐Huei Tsai, Jung‐Chien Cheng, et al.. (2017). APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner. Gynecologic Oncology. 147(3). 663–671. 33 indexed citations
6.
7.
Behzad, Hayedeh, et al.. (2014). Mechanism of mast cell adhesion to human tenocytes in vitro. Journal of Orthopaedic Research®. 33(1). 9–16. 3 indexed citations
8.
Tsai, Shu‐Huei, et al.. (2013). Cytoskeletal protein vimentin interacts with and regulates peroxisome proliferator‐activated receptor gamma via a proteasomal degradation process. Journal of Cellular Biochemistry. 114(7). 1559–1567. 4 indexed citations
9.
Chang, Emily Yun‐Chia, Shu‐Huei Tsai, Chia‐Tung Shun, et al.. (2012). Prostaglandin Reductase 2 Modulates ROS-Mediated Cell Death and Tumor Transformation of Gastric Cancer Cells and Is Associated with Higher Mortality in Gastric Cancer Patients. American Journal Of Pathology. 181(4). 1316–1326. 14 indexed citations
10.
Chang, Yi‐Cheng, Pi‐Hua Liu, Yen‐Feng Chiu, et al.. (2012). Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis. Journal of Molecular Medicine. 90(7). 847–858. 9 indexed citations
11.
Tsai, Shu‐Huei, Yi‐Cheng Chang, Ching‐Jin Chang, et al.. (2012). The Role of Nocturnin in Early Adipogenesis and Modulation of Systemic Insulin Resistance in Human. Obesity. 20(8). 1558–1565. 13 indexed citations
12.
Chen, Linda, et al.. (2006). Evidence for a protective role for adiponectin in osteoarthritis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(8). 711–718. 180 indexed citations
13.
Lin, Shyr‐Yi, Yuan‐Soon Ho, Shiann Pan, et al.. (2003). Involvement of c‐jun N‐terminal kinase activation in 15‐deoxy‐δ12,14‐prostaglandin J2–and prostaglandin A1–induced apoptosis in AGS gastric epithelial cells. Molecular Carcinogenesis. 37(1). 16–24. 30 indexed citations
14.
15.
Tsai, Shu‐Huei, et al.. (2002). Arsenite stimulates cyclooxygenase‐2 expression through activating IκB kinase and nuclear factor κB in primary and ECV304 endothelial cells. Journal of Cellular Biochemistry. 84(4). 750–758. 62 indexed citations
16.
Lin, Chih‐Li, et al.. (2001). Inhibition of melanoma growth and metastasis by combination with (−)‐epigallocatechin‐3‐gallate and dacarbazine in mice. Journal of Cellular Biochemistry. 83(4). 631–642. 109 indexed citations
17.
18.
Chen, Yen‐Chou, Shu‐Huei Tsai, Shing‐Chuan Shen, Jen‐Kun Lin, & W. Robert Lee. (2001). Alternative activation of extracellular signal-regulated protein kinases in curcumin and arsenite-induced HSP70 gene expression in human colorectal carcinoma cells. European Journal of Cell Biology. 80(3). 213–221. 40 indexed citations
19.
Tsai, Shu‐Huei, et al.. (2001). Suppression of Fas ligand expression on endothelial cells by arsenite through reactive oxygen species. Toxicology Letters. 123(1). 11–19. 29 indexed citations
20.
Tsai, Shu‐Huei, Yu‐Chih Liang, Shoei‐Yn Lin‐Shiau, & Jen‐Kun Lin. (1999). Suppression of TNFα‐mediated NFκb activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells. Journal of Cellular Biochemistry. 74(4). 606–615. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui Chang Breakdown of academic impact, for papers by Jun Hee Lim Breakdown of academic impact, for papers by Jean‐François Savouret Breakdown of academic impact, for papers by Nica M. Borradaile Breakdown of academic impact, for papers by Yoo‐Hyun Lee Breakdown of academic impact, for papers by Keon Wook Kang Breakdown of academic impact, for papers by Marthandam Asokan Shibu Breakdown of academic impact, for papers by Pedro Michaluart Breakdown of academic impact, for papers by Zhou‐Yan Bian Breakdown of academic impact, for papers by Roberta Giordo
Rankless by CCL
2026